Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2279]

Choosing cancer medicines wisely in Africa

Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania

Choosing cancer medicines wisely in Africa ( Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania )

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA...

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer...

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru

Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )

Patient-derived iPSCs faithfully represent the genetic diversity and cellular...

Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML ( Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA )

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh...

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes...

Dr Joshua Choe - Columbia University, New York City, USA

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death ( Dr Joshua Choe - Columbia University, New York City, USA )

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru

Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody...

Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer...

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )

ALLO-316 demonstrates encouraging anti-tumour activity for patients with...

Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with...

Prof Pierce Chow - Duke-NUS Medical School, Singapore

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC ( Prof Pierce Chow - Duke-NUS Medical School, Singapore )

IO-108 shows promising results in the treatment of advanced relapsed or...

Dr Matthew Taylor - Providence Cancer Institute, Portland, USA

$IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours ( Dr Matthew Taylor - Providence Cancer Institute, Portland, USA )$

More from ecancer